Turn Therapeutics (TTRX) Change in Accured Expenses (2024 - 2026)

Turn Therapeutics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$613464.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 2853.75% year-over-year to -$613464.0; the TTM figure through Mar 2026 stood at $80654.0 (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 1015.95% from the prior year.
• Change in Accured Expenses was -$613464.0 for Q1 2026 at Turn Therapeutics, down from $664303.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $664303.0 in Q4 2025 to a low of -$613464.0 in Q1 2026.
• Historically, Change in Accured Expenses has averaged $20163.5 across 3 years, with a median of $14907.5 in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses surged 1213.27% in 2025, then tumbled 2853.75% in 2026.
• A 3-year view of Change in Accured Expenses shows it stood at $50584.0 in 2024, then soared by 1213.27% to $664303.0 in 2025, then tumbled by 192.35% to -$613464.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$613464.0 (Q1 2026), $664303.0 (Q4 2025), and -$20769.0 (Q1 2025), per Business Quant data.